CRH Medical (NYSEAMERICAN:CRHM) released its quarterly earnings results on Wednesday. The company reported $0.02 earnings per share for the quarter, hitting the consensus estimate of $0.02, Morningstar.com reports. The company had revenue of $32.02 million for the quarter, compared to analyst estimates of $31.40 million.
Shares of NYSEAMERICAN:CRHM opened at $2.97 on Friday. CRH Medical has a 1-year low of $2.40 and a 1-year high of $4.50.
Several brokerages recently issued reports on CRHM. TD Securities reaffirmed a “buy” rating on shares of CRH Medical in a research note on Tuesday, January 8th. Zacks Investment Research raised shares of CRH Medical from a “sell” rating to a “hold” rating in a research note on Monday, November 26th.
Institutional investors have recently made changes to their positions in the business. Mackenzie Financial Corp purchased a new position in shares of CRH Medical in the fourth quarter valued at $1,413,000. JPMorgan Chase & Co. raised its position in shares of CRH Medical by 38.0% in the third quarter. JPMorgan Chase & Co. now owns 1,486,400 shares of the company’s stock worth $5,871,000 after acquiring an additional 409,100 shares during the period. Morgan Stanley raised its position in shares of CRH Medical by 116.7% in the third quarter. Morgan Stanley now owns 3,653,460 shares of the company’s stock worth $14,432,000 after acquiring an additional 1,967,537 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of CRH Medical by 205.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,808,899 shares of the company’s stock worth $7,193,000 after acquiring an additional 1,217,234 shares during the period. Finally, Renaissance Technologies LLC raised its position in shares of CRH Medical by 77.4% in the third quarter. Renaissance Technologies LLC now owns 680,400 shares of the company’s stock worth $2,692,000 after acquiring an additional 296,800 shares during the period.
ILLEGAL ACTIVITY NOTICE: This report was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/4223731/crh-medical-crhm-releases-quarterly-earnings-results-hits-estimates.html.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Featured Story: Current Ratio
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.